Yes, weight loss benefits certain liver diseases, especially MAFLD and NASH-related cirrhosis, by reducing hepatic fat and inflammation
The glucagon component adds thermogenic and lipolytic signaling pathways not present in GLP-1-only or dual GIP/GLP-1 compounds
All individuals measured have normal sleep, 24 h abstinence from physical exercise, 3 h from smoking and coffee drinking and they had not been ill or followed a specific diet in the last 7 days
Clinicians can now use GLP-1s more confidently as part of holistic, individualized care for diabetes and obesity
Unlike a traditional clinic where you wait weeks for an appointment, the virtual model uses a parallel processing approach where data collection and identity verification happen simultaneously
That's a remarkable headline number, and it's driven significant interest despite the limited human data available